SCHEMBL2983501

SCHEMBL2983501

COc1ccc(N)cc1NS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.57
MAPT P10636 1/20 0.56
LMNA P02545 5/20 0.55
ALDH1A1 P00352 4/20 0.55
TSHR P16473 3/20 0.55
JAK2 O60674 1/20 0.55
TP53 P04637 3/20 0.52
KMT2A Q03164 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
HTT P42858 2/20 0.52
HPGD P15428 2/20 0.51
POLB P06746 1/20 0.51
CYP2C9 P11712 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
HTR1A P08908 1/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23229428 0.86 ALDH1A1 (0.64) MAPTLMNAALDH1A1TSHRJAK2
SCHEMBL4730290 0.84 LMNA (0.71) GHSRMAPTLMNAALDH1A1TSHR
SCHEMBL2991423 0.83 ALDH1A1 (0.50) MAPTLMNAALDH1A1TSHRJAK2
SCHEMBL20577926 0.82 LMNA (0.71) MAPTLMNAALDH1A1TSHRJAK2
SCHEMBL2987399 0.81 ACLY (0.60) ALDH1A1TSHRTP53KMT2ANPSR1
SCHEMBL4801671 0.81 LMNA (0.54) GHSRMAPTLMNAALDH1A1TSHR
SCHEMBL8013885 0.81 TP53 (0.54) MAPTLMNAALDH1A1TSHRJAK2
SCHEMBL11685580 0.81 LMNA (0.54) LMNAALDH1A1TSHRJAK2TP53
SCHEMBL12786357 0.80 ALDH1A1 (0.54) GHSRMAPTLMNAALDH1A1TSHR
SCHEMBL2994570 0.80 ALDH1A1 (0.79) GHSRMAPTLMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed
EP-2007716-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 EP disclosed
WO-2007118852-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR GHSR 1/4885MAPT 4610/4885LMNA 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.